Document is current
Any future updates will be listed below
-
Authors
Valentin, Heike
Rau, Henriette
Fiedler-Lacombe, Lizon
Blumentritt, Arne
Heim, Ekaterina
Rudolph, Alexander
Leyh, Katrin
Kraus, Monika
Lorenz-Depiereux, Bettina
Chaplinskaya, Irina
Schäfer, Christian
Schaller, Jens
Vehreschild, Joerg Janne
Stecher, Melanie
Scherer, Margarete
Witzenrath, Martin
Balzuweit, Beate
Schreiber, Stefan
Bahmer, Thomas
Lieb, Wolfgang
Cordes, Steffen
Hoffmann, Wolfgang
Hanß, Sabine
Stahl, Dana
-
Funding
Funding for this research was provided by:
NUM/NUKLEUS (01KX2021, 01KX2021, 01KX2021, 01KX2021, 01KX2021, 01KX2021)
Deutsches Zentrum für Herz-Kreislaufforschung (81X1400101, 81X1400101, 81X1400101)
Universitätsmedizin Greifswald
- License Information
-
More Information
Article History
Received: 16 August 2022
Accepted: 6 March 2025
First Online: 29 May 2025
Declarations
:
: All methods were performed in accordance with the relevant guidelines and regulations. For the NAPKON project positive votes from responsible local ethics committees were obtained (for single study ICs in one study site or for all study ICs in a federal state, including all participating study sites). Each NAPKON-participant had to give written informed consent prior to be included in the NAPKON study.The overall responsible contact for ethical procedures related to NAPKON is:Ethics Coordination (EC), Helmholtz Zentrum München, Abteilung Molekulare Epidemiologie (AME), Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.This paper refers only to withdrawal procedures regarding informed consent documents.
: Not applicable.
: The authors declare no competing interests.
